Nomura Asset Management’s Novavax NVAX Stock Holding History

Nomura Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,990	Closed	-$1.03M	–	1561
2022 Q1	$1.03M	Hold	13,990	–	–	0.01%	834
2021 Q4	$2M	Buy	13,990 +1,100	+9%	+$189K	0.01%	746
2021 Q3	$2.67M	Hold	12,890	–	–	0.02%	637
2021 Q2	$2.74M	Buy	+12,890	New	+$2.36M	0.02%	647

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nomura Asset Management's NVAX Position: Q2 2022 in Review

Nomura Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 13,990 shares — an estimated $1.03M sold.

Nomura Asset Management first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $2.74M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Nomura Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Nomura Asset Management sold 13,990 Novavax shares in Q2 2022, an estimated $1.03M.
Nomura Asset Management first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
Nomura Asset Management's Novavax position peaked at $2.74M in Q2 2021.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Nomura Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.